Share your insights

Help us by sharing what content you've recieved in your exams


Anxiety disorder: generalised

Background knowledge 🧠

Definition

  • Generalised Anxiety Disorder (GAD) is a chronic mental health condition characterized by excessive, uncontrollable worry about a variety of topics.
  • Worry is disproportionate to the actual situation, pervasive, and lasts for at least six months.
  • Accompanied by physical and psychological symptoms that impair daily functioning.

Epidemiology

  • Lifetime prevalence of GAD is estimated at 5-7% in the general population.
  • More common in females than males, with a ratio of 2:1.
  • Typically presents in early adulthood but can occur at any age.
  • Often coexists with other psychiatric disorders, particularly depression and other anxiety disorders.

Aetiology and Pathophysiology

  • Multifactorial origin: genetic predisposition, environmental factors, and neurobiological influences.
  • Dysregulation of neurotransmitters, particularly serotonin, norepinephrine, and gamma-aminobutyric acid (GABA).
  • Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis, leading to excessive stress hormone release.
  • Chronic stress and early life adversity contribute to the development of GAD.

Types

  • Generalised Anxiety Disorder (GAD): chronic, pervasive anxiety without specific triggers.
  • Other related disorders include Panic Disorder, Social Anxiety Disorder, and specific phobias, though they differ in their focus and triggers.
  • GAD is distinguished by its broad and persistent nature.

Clinical Features 🌑️

Symptoms

  • Excessive worry about various domains (e.g., work, health, social relationships) that is difficult to control.
  • Restlessness or feeling keyed up or on edge.
  • Easily fatigued, difficulty concentrating, or mind going blank.
  • Irritability, muscle tension, and sleep disturbances (difficulty falling or staying asleep, or restless, unsatisfying sleep).
  • Physical symptoms often include gastrointestinal discomfort, headaches, and palpitations.
  • Symptoms cause significant distress or impairment in social, occupational, or other important areas of functioning.

Signs

  • Physical signs are generally nonspecific and may include muscle tension, tremors, and sweating.
  • Patients may exhibit an exaggerated startle response.
  • May appear restless or fidgety during examination.
  • Often no specific findings on physical examination.

Investigations πŸ§ͺ

Tests

  • Primarily a clinical diagnosis based on history and symptoms.
  • Screening tools: GAD-7 questionnaire commonly used to assess severity.
  • Rule out other conditions: thyroid function tests, complete blood count, and metabolic panel to exclude medical causes of anxiety.
  • Consider ECG if palpitations or chest pain are present to exclude cardiac causes.
  • Psychological assessment may be warranted to evaluate comorbid conditions such as depression.

Management πŸ₯Ό

Management

  • First-line: Cognitive Behavioural Therapy (CBT) is the gold standard.
  • Pharmacological: SSRIs (e.g., sertraline) are first-line medications, followed by SNRIs (e.g., venlafaxine) if SSRIs are ineffective.
  • Pregabalin is an alternative for patients who do not tolerate SSRIs/SNRIs.
  • Benzodiazepines may be used short-term for severe anxiety but are not recommended long-term due to dependence risk.
  • Lifestyle modifications: Regular exercise, sleep hygiene, and stress management techniques.
  • Patient education and self-help resources (e.g., online CBT) are important for long-term management.

Complications

  • Increased risk of developing comorbid depression.
  • Higher likelihood of substance misuse as a coping mechanism.
  • Chronic physical conditions (e.g., hypertension, cardiovascular disease) may worsen due to ongoing stress.
  • Impaired social and occupational functioning, leading to decreased quality of life.

Prognosis

  • Chronic condition with a variable course; many patients experience fluctuating symptoms.
  • Relapses are common, particularly if treatment is discontinued.
  • Good response to treatment, particularly CBT and medication.
  • Prognosis improves with early intervention and adherence to treatment.

Key Points

  • GAD is a common and chronic mental health condition characterized by excessive, uncontrollable worry.
  • Early recognition and treatment are crucial to prevent complications.
  • Management typically involves CBT, SSRIs, and lifestyle modifications.
  • Prognosis varies, but adherence to treatment significantly improves outcomes.

No comments yet πŸ˜‰

Leave a Reply

General practice